You searched for "RPE"
Review evaluates efficacy of eye protection equipment to protect against Covid-19
4 April 2020
Researchers from the University of Oxford have concluded that there is "no direct evidence from randomised trials that eye protection equipment alone prevents transmission of COVID-19."
Sensitive cilia – eyelashes in health and disease
5 October 2020
| Jonathan CP Roos, Rachna Murthy
|
EYE - Cornea, EYE - Orbit, EYE - Oculoplastic, EYE - General
In health our eyelashes protect the eyes, but in disease they can disfigure, impair quality of life and threaten vision. In this review the authors discuss aspects of lashes that are relevant to all professionals working near the eyes and...
Are social media promoting ocular protection in the community?
During the Covid-19 pandemic, many countries worldwide introduced lockdown measures to control infection, causing people to spend more time at home. This resulted in reports of increasing incidences of do-it-yourself (DIY)-related trauma. When the Covid-19 pandemic started in December 2019,...COVID-19 and Ophthalmology: RCOphth, ICEH and COECSA joint webinar
13 August 2020
| Elanor Watts, Victor Hu, Will Dean, John Buchan, John Nkurikiye, Mike Burdon, Josiah Onyango, Marcia Zondervan
|
EYE - General
The Royal College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) and the Royal College of Ophthalmologists (the Royal College) have had a successful VISION 2020 LINK partnership for over 12 years. The partnership was established by the VISION...
Diabetic Macular Oedema
1 December 2013
| Pouya Alaghband
Diabetes mellitus is a metabolic disorder that affects the metabolism of all three categories of carbohydrates, lipids and proteins. This condition is characterised by chronic hyperglycaemia [1]. This can cause end organ damage. The estimated worldwide diabetes prevalence for 2010...
Easter Weekend sees the start of Innovia Face Visor production
15 April 2020
Innovia Medical Group has announced that production of its Innovia Face Visor is now underway.
Cancer associated retinopathy
Abdul Muhyemin Tarin reviews the presentation, pathophysiology and management of this paraneoplastic syndrome. Case presentation A 60-year-old hypermetropic female patient presented with several months’ history of painless blurred vision. Visual acuity (VA) was 6/24 and 6/9-1 in right and left...25 years of OCT
David Huang first described optical coherence tomography (OCT) in 1991, in his seminal paper on the subject in Science. This method developed the work of others on ophthalmic interferometry, which essentially showed that measuring reflected light could be used to...What’s next in retinal imaging? Faster, deeper and full-on
Fast-evolving technological leaps are opening the way toward clinically useful ocular coherence angiography, generating 3-dimensional microvasculature maps without intravenous dye injection, as well as whole-eye imaging, handheld patient-operated optical coherence tomography (OCT) devices and, for challenging vitreoretinal procedures, integrated intraoperative...DMEK vs. UT-DSAEK: has the debate been finally concluded?
In recent years the surgical treatment of corneal endothelial dystrophy has progressed tremendously. Descemet’s membrane endothelial keratoplasty (DMEK) is the newest iteration in the line of rapid surgical advances that has taken place. However, the previously accepted gold standard prior...Assessing everyday visual function in dry AMD – what matters to the person?
1 April 2019
| Bethany E Higgins, Deanna J Taylor, David P Crabb (Prof)
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...
Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service
4 August 2021
| Jane Ashworth, Tsveta Ivanova, Susmito Biswas, Assad Jalil, Georgina Hall, Rebecca Redmond, Graeme CM Black (Prof), William Newman, Neil Parry, Jane CB Gray, Charlotte Skitterall
|
EYE - Paediatrics, EYE - Vitreo-Retinal, EYE - General
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...
